{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:23:52Z","timestamp":1790961832158,"version":"4.1.0"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi230443-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Efficient screening tools that effectively identify substance use disorders (SUDs) among youths are needed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi230443-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the psychometric properties of 3 brief substance use screening tools (Screening to Brief Intervention [S2BI]; Brief Screener for Tobacco, Alcohol, and Drugs [BSTAD]; and Tobacco, Alcohol, Prescription Medication, and Other Substances [TAPS]) with adolescents aged 12 to 17 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi230443-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>\n                      This cross-sectional validation study was conducted from July 1, 2020, to February 28, 2022. Participants aged 12 to 17 years were recruited virtually and in person from 3 health care settings in Massachusetts: (1) an outpatient adolescent SUD treatment program at a pediatric hospital, (2) an adolescent medicine program at a community pediatric practice affiliated with an academic institution, and (3) 1 of 28 participating pediatric primary care practices. Participants were randomly assigned to complete 1 of the 3 electronic screening tools via self-administration, followed by a brief electronic assessment battery and a research assistant\u2013administered diagnostic interview as the criterion standard measure for\n                      <jats:italic>Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition<\/jats:italic>\n                      (\n                      <jats:italic>DSM-5<\/jats:italic>\n                      ) diagnoses of SUDs. Data were analyzed from May 31 to September 13, 2022.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi230443-7\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>\n                      The main outcome was a\n                      <jats:italic>DSM-5<\/jats:italic>\n                      diagnosis of tobacco\/nicotine, alcohol, or cannabis use disorder as determined by the criterion standard World Mental Health Composite International Diagnostic Interview Substance Abuse Module. Classification accuracy of the 3 substance use screening tools was assessed by examining the agreement between the criterion, using sensitivity and specificity, based on cut points for each tool for use disorder, chosen a priori from previous studies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi230443-8\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>This study included 798 adolescents, with a mean (SD) age of 14.6 (1.6) years. The majority of participants identified as female (415 [52.0%]) and were White (524 [65.7%]). High agreement between screening results and the criterion standard measure was observed, with area under the curve values ranging from 0.89 to 1 for nicotine, alcohol, and cannabis use disorders for each of the 3 screening tools.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi230443-9\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>These findings suggest that screening tools that use questions on past-year frequency of use are effective for identifying adolescents with SUDs. Future work could examine whether these tools have differing properties when used with different groups of adolescents in different settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.14422","type":"journal-article","created":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T11:33:20Z","timestamp":1684755200000},"page":"e2314422","source":"Crossref","is-referenced-by-count":44,"title":["Assessment of Screening Tools to Identify Substance Use Disorders Among Adolescents"],"prefix":"10.1001","volume":"6","author":[{"given":"Sharon","family":"Levy","sequence":"first","affiliation":[{"name":"Division of Addiction Medicine, Boston Children\u2019s Hospital, Boston, Massachusetts"},{"name":"Department of Pediatrics, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Brogna","sequence":"additional","affiliation":[{"name":"Division of Addiction Medicine, Boston Children\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Machiko","family":"Minegishi","sequence":"additional","affiliation":[{"name":"Division of Addiction Medicine, Boston Children\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetha","family":"Subramaniam","sequence":"additional","affiliation":[{"name":"Center for Clinical Trials Network, National Institute on Drug Abuse, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"McCormack","sequence":"additional","affiliation":[{"name":"Emmes Company, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Kline","sequence":"additional","affiliation":[{"name":"Emmes Company, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Menzin","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Harvard Medical School, Boston, Massachusetts"},{"name":"Division of General Pediatrics, Boston Children\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Allende-Richter","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Harvard Medical School, Boston, Massachusetts"},{"name":"Division of General Pediatrics, Boston Children\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Fuller","sequence":"additional","affiliation":[{"name":"Division of Addiction Medicine, Boston Children\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitra","family":"Lewis","sequence":"additional","affiliation":[{"name":"Emmes Company, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Collins","sequence":"additional","affiliation":[{"name":"Emmes Company, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zach","family":"Hubbard","sequence":"additional","affiliation":[{"name":"Emmes Company, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon G.","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Friends Research Institute, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Weiss","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Harvard Medical School, Boston, Massachusetts"},{"name":"Division of Alcohol, Drugs, and Addiction, McLean Hospital, Belmont, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elissa","family":"Weitzman","sequence":"additional","affiliation":[{"name":"Division of Addiction Medicine, Boston Children\u2019s Hospital, Boston, Massachusetts"},{"name":"Department of Pediatrics, Harvard Medical School, Boston, Massachusetts"},{"name":"Division of Adolescent and Young Adult Medicine, Boston Children\u2019s Hospital, Boston, Massachusetts"},{"name":"Computational Health Informatics Program, Boston Children\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,5,22]]},"reference":[{"issue":"4 suppl","key":"zoi230443r1","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/j.jadohealth.2021.11.033","article-title":"Young adult substance use and healthcare use associated with screening, brief intervention and referral to treatment in pediatric primary care.","volume":"71","author":"Sterling","year":"2022","journal-title":"J Adolesc Health"},{"issue":"5","key":"zoi230443r2","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s11920-012-0304-9","article-title":"Integrating substance use treatment into adolescent health care.","volume":"14","author":"Sterling","year":"2012","journal-title":"Curr Psychiatry Rep"},{"issue":"1","key":"zoi230443r3","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-009191","article-title":"Three-year outcomes after brief treatment of substance use and mood symptoms.","volume":"147","author":"Parthasarathy","year":"2021","journal-title":"Pediatrics"},{"issue":"9","key":"zoi230443r4","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1001\/jamapediatrics.2014.774","article-title":"An electronic screen for triaging adolescent substance use by risk levels.","volume":"168","author":"Levy","year":"2014","journal-title":"JAMA Pediatr"},{"issue":"5","key":"zoi230443r5","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1542\/peds.2013-2346","article-title":"Validity of brief screening instrument for adolescent tobacco, alcohol, and drug use.","volume":"133","author":"Kelly","year":"2014","journal-title":"Pediatrics"},{"key":"zoi230443r6","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cct.2016.07.013","article-title":"Design of the NIDA Clinical Trials Network validation study of Tobacco, Alcohol, Prescription Medications, and Substance Use\/Misuse (TAPS) tool.","volume":"50","author":"Wu","year":"2016","journal-title":"Contemp Clin Trials"},{"issue":"11","key":"zoi230443r9","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1097\/01.MLR.0000093487.78664.3C","article-title":"The Patient Health Questionnaire-2: validity of a two-item depression screener.","volume":"41","author":"Kroenke","year":"2003","journal-title":"Med Care"},{"issue":"5","key":"zoi230443r10","doi-asserted-by":"publisher","first-page":"317","DOI":"10.7326\/0003-4819-146-5-200703060-00004","article-title":"Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection.","volume":"146","author":"Kroenke","year":"2007","journal-title":"Ann Intern Med"},{"issue":"9","key":"zoi230443r13","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1097\/JTO.0b013e3181ec173d","article-title":"Receiver operating characteristic curve in diagnostic test assessment.","volume":"5","author":"Mandrekar","year":"2010","journal-title":"J Thorac Oncol"},{"issue":"4","key":"zoi230443r14","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.jadohealth.2018.10.009","article-title":"Disclosure of adolescent substance use in primary care: comparison of routine clinical screening and anonymous research interviews.","volume":"64","author":"Gryczynski","year":"2019","journal-title":"J Adolesc Health"},{"issue":"7","key":"zoi230443r15","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1001\/archpedi.160.7.739","article-title":"Age at drinking onset and alcohol dependence: age at onset, duration, and severity.","volume":"160","author":"Hingson","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"10","key":"zoi230443r16","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1001\/archpsyc.60.10.1033","article-title":"Early reactions to cannabis predict later dependence.","volume":"60","author":"Fergusson","year":"2003","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"zoi230443r17","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1080\/08897077.2021.1890675","article-title":"Alcohol trajectories and subsequent risk for opioid misuse in a cohort of urban adolescents.","volume":"42","author":"Thrul","year":"2021","journal-title":"Subst Abus"},{"issue":"6","key":"zoi230443r18","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1001\/jamapediatrics.2013.1095","article-title":"Electronic media-based health interventions promoting behavior change in youth: a systematic review.","volume":"167","author":"Hieftje","year":"2013","journal-title":"JAMA Pediatr"},{"issue":"9","key":"zoi230443r19","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1093\/ntr\/ntu227","article-title":"Tobacco smoking, nicotine dependence, and patterns of prescription opioid misuse: results from a nationally representative sample.","volume":"17","author":"Zale","year":"2015","journal-title":"Nicotine Tob Res"},{"issue":"1","key":"zoi230443r20","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-1211","article-title":"Substance use screening, brief intervention, and referral to treatment.","volume":"138","author":"Levy","year":"2016","journal-title":"Pediatrics"},{"issue":"6","key":"zoi230443r22","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/josh.v90.6","article-title":"Student experience of school screening, brief intervention, and referral to treatment.","volume":"90","author":"Chadi","year":"2020","journal-title":"J Sch Health"},{"issue":"6","key":"zoi230443r23","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.6258","article-title":"Effect of computer-based substance use screening and brief behavioral counseling vs usual care for youths in pediatric primary care: a pilot randomized clinical trial.","volume":"2","author":"Knight","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"6","key":"zoi230443r24","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1542\/peds.2011-1624","article-title":"Computer-facilitated substance use screening and brief advice for teens in primary care: an international trial.","volume":"129","author":"Harris","year":"2012","journal-title":"Pediatrics"},{"issue":"14","key":"zoi230443r25","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1001\/jama.2022.2847","article-title":"Trends in drug overdose deaths among US adolescents, January 2010 to June 2021.","volume":"327","author":"Friedman","year":"2022","journal-title":"JAMA"},{"issue":"2","key":"zoi230443r26","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jadohealth.2007.07.011","article-title":"The role of parental consent in adolescent substance use research.","volume":"42","author":"Rojas","year":"2008","journal-title":"J Adolesc Health"},{"issue":"6","key":"zoi230443r27","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.jadohealth.2018.07.002","article-title":"The protective effects of school connectedness on substance use and physical activity.","volume":"63","author":"Weatherson","year":"2018","journal-title":"J Adolesc Health"},{"key":"zoi230443r28","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1093\/cid\/ciac311","article-title":"The impact of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic on substance use in the United States.","volume":"75","author":"Ross","year":"2022","journal-title":"Clin Infect Dis"},{"key":"zoi230443r12","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013","edition":"5th ed"},{"key":"zoi230443r21","volume-title":"Bright Futures Guidelines for Health Supervision of Infants, Children, and Adolescents","author":"Hagan","year":"2008","edition":"3rd ed"},{"key":"zoi230443r7","unstructured":"Miech? RA, Johnston? LD, O\u2019Malley? PM, Bachman? JG, Schulenberg? JE. Monitoring the Future National Survey Results on Drug Use, 1975-2015. Volume I, Secondary School Students. 2016. Accessed February 16, 2022. https:\/\/monitoringthefuture.org\/wp-content\/uploads\/2022\/08\/mtf-vol1_2021.pdf"},{"key":"zoi230443r8","unstructured":"World Health Organization. The World Health Organization World Mental Health Composite International Diagnostic Interview (WHO WMH-CIDI). 1990. Accessed May 26, 2022. https:\/\/www.hcp.med.harvard.edu\/wmhcidi\/about-the-who-wmh-cidi\/"},{"key":"zoi230443r11","unstructured":"National Institutes of Health. Guidelines for the review of inclusion on the basis of sex\/gender, race, ethnicity, and age. Updated March 18, 2019. Accessed May 26, 2022. https:\/\/grants.nih.gov\/grants\/peer\/guidelines_general\/Review_Human_Subjects_Inclusion.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2805055\/levy_2023_oi_230443_1683743127.56831.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T11:33:30Z","timestamp":1684755210000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2805055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,22]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.14422","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,22]]}}}